Provided by Tiger Fintech (Singapore) Pte. Ltd.

Matinas BioPharma Holdings, Inc

0.5999
+0.04287.68%
Post-market: 0.59990.00000.00%19:43 EDT
Volume:11.52K
Turnover:6.65K
Market Cap:3.05M
PE:-0.12
High:0.5999
Open:0.5900
Low:0.5601
Close:0.5571
Loading ...

North American Morning Briefing: Stock Futures Volatile Amid Selloff in Treasuries

Dow Jones
·
09 Apr

Matinas BioPharma Holdings Inc - Eric Ende Resigns as Chairman of Matinas BioPharma

THOMSON REUTERS
·
15 Mar

BRIEF-Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors

Reuters
·
14 Feb

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of DR. Robin L. Smith to the Board of Directors

THOMSON REUTERS
·
14 Feb

BRIEF-Matinas Biopharma Appoints Evelyn D’An To Board Of Directors As Audit Committee Chair

Reuters
·
07 Feb

Matinas BioPharma appoints Evelyn D’An to board of directors

TIPRANKS
·
07 Feb

Matinas BioPharma Appoints Evelyn D’an to Board of Directors as Audit Committee Chair

THOMSON REUTERS
·
07 Feb

Press Release: Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair

Dow Jones
·
07 Feb

111 Equity Group-Continue to Engage in Discussions With Mtnb's Management in Effort to Enhance Shareholder Value in Connection With Strategic Review

THOMSON REUTERS
·
24 Jan

Matinas BioPharma receives NYSE noncompliance notice

TIPRANKS
·
11 Jan

BRIEF-Matinas BioPharma Receives NYSE Noncompliance Notice

Reuters
·
11 Jan

Matinas BioPharma Receives Nyse Noncompliance Notice

THOMSON REUTERS
·
11 Jan

Amex Halt Add Info Lst 0.990000

THOMSON REUTERS
·
08 Jan

Chaim Herzog - Intends to Engage in Discussion With Matinas BioPharma's Management on Engagement of Advisor Related to Any Asset Sale

THOMSON REUTERS
·
07 Jan

Chaim Herzog Reports 5.17% Stake in Matinas BioPharma Holdings Inc as of Jan 2, 2025 - SEC Filing

THOMSON REUTERS
·
07 Jan

Matinas BioPharma Faces Uncertain Future After Halting MAT2203 Development

TIPRANKS
·
15 Nov 2024

Matinas BioPharma downgraded to Neutral from Buy at Alliance Global Partners

TIPRANKS
·
02 Nov 2024

Matinas BioPharma Cut to Hold From Buy by Maxim Group

Dow Jones
·
01 Nov 2024

Maxim Downgrades Matinas BioPharma to Hold From Buy

MT Newswires Live
·
01 Nov 2024

Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results

Benzinga
·
01 Nov 2024